Clinical Trial Update: Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (4 to 15 y) (BY9010/M1-205) [Phase 3]

View source ↗

Summary

This clinical trial update reports on a Phase 3 study comparing once-daily ciclesonide to twice-daily fluticasone propionate for pediatric asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone propionate (Fluticasone propionate)
• ciclesonide (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED